255 related articles for article (PubMed ID: 23447672)
21. Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition.
Pignatelli J; Tumbarello DA; Schmidt RP; Turner CE
J Cell Biol; 2012 Apr; 197(3):421-37. PubMed ID: 22529104
[TBL] [Abstract][Full Text] [Related]
22. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
Woosley AN; Dalton AC; Hussey GS; Howley BV; Mohanty BK; Grelet S; Dincman T; Bloos S; Olsen SK; Howe PH
Oncogene; 2019 May; 38(20):3794-3811. PubMed ID: 30692635
[TBL] [Abstract][Full Text] [Related]
23. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.
Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P
Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979
[TBL] [Abstract][Full Text] [Related]
24. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
Northey JJ; Chmielecki J; Ngan E; Russo C; Annis MG; Muller WJ; Siegel PM
Mol Cell Biol; 2008 May; 28(10):3162-76. PubMed ID: 18332126
[TBL] [Abstract][Full Text] [Related]
25. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
26. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
27. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
28. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
[TBL] [Abstract][Full Text] [Related]
29. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
30. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
Agajanian M; Runa F; Kelber JA
Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
[TBL] [Abstract][Full Text] [Related]
31. LIM-domain proteins in transforming growth factor β-induced epithelial-to-mesenchymal transition and myofibroblast differentiation.
Järvinen PM; Laiho M
Cell Signal; 2012 Apr; 24(4):819-25. PubMed ID: 22182513
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion.
Dai M; Al-Odaini AA; Fils-Aimé N; Villatoro MA; Guo J; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2013 Jun; 15(3):R49. PubMed ID: 23786849
[TBL] [Abstract][Full Text] [Related]
33. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
[TBL] [Abstract][Full Text] [Related]
35. Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition.
Wang Z; Liu Z; Yu G; Nie X; Jia W; Liu RE; Xu R
Neurochem Res; 2018 Mar; 43(3):760-774. PubMed ID: 29423667
[TBL] [Abstract][Full Text] [Related]
36. Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells.
He J; Ma G; Qian J; Zhu Y; Liang M; Yao N; Ding Q; Chen L; Liu X; Xia T; Wang S
Med Sci Monit; 2017 Apr; 23():1583-1596. PubMed ID: 28364518
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer.
Katara GK; Kulshrestha A; Schneiderman S; Riehl V; Ibrahim S; Beaman KD
Mol Oncol; 2020 Jan; 14(1):211-224. PubMed ID: 31725949
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
39. The focal adhesion and nuclear targeting capacity of the LIM-containing lipoma-preferred partner (LPP) protein.
Petit MM; Meulemans SM; Van de Ven WJ
J Biol Chem; 2003 Jan; 278(4):2157-68. PubMed ID: 12441356
[TBL] [Abstract][Full Text] [Related]
40. TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer.
Wendt MK; Schiemann BJ; Parvani JG; Lee YH; Kang Y; Schiemann WP
Oncogene; 2013 Apr; 32(16):2005-15. PubMed ID: 22710711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
